Lotus Pharmaceuticals to Showcase at 62nd PHARMCHINA
Ft Lauderdale, Florida 11/25/2009 01:05 AM GMT (TransWorldNews)
Lotus Pharmaceuticals, Inc. (OTC.BB: LTUS) will showcase at the 62nd PHARMCHINA as a member of the Beijing pharmaceutical delegation. The exhibition is being held at the International Convention Center, Chengdu from November 26-28, 2009. As a member of the delegation, Lotus will market their drugs that have established certain market share in China and introduce three potential new drugs which are subject to the State FDA approval.
Simply Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter
About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )
Lotus Pharmaceuticals, Inc. is a growing developer and producer of prescription drugs and a licensed national seller of pharmaceutical items in the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus' current drug development pipeline is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. More than 8,000 products are sold by Liang Fang directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces.
Sign up for the free Simply Best Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow Simply Best Penny Stocks on Twitter: http://www.Twitter.com/simplybestps
About Us
Simply Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
info@simplybestpennystocks.com
www.simplybestpennystocks.com


Email Article to a friend
|
View Profile
Visit Blogs
|

NEWS ALERTS
Receive alerts for
Simply Best Penny Stocks
to your inbox.
Sign up for TransWorldNews Alerts

TransWorldNews, Inc. and its affiliate sites disclaim all liability for information and content provided by clients and appearing within their news and press releases.
